Cevimeline Hydrochloride Capsule
Product Images NDC 59651-422

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cevimeline Hydrochloride (NDC 59651-422). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (30 mg (100 Capsules Bottle))

Package Label-principal Display Panel (30 mg (100 Capsules Bottle))
Cevimeline Hydrochloride Capsules 30 mg label showing the NDC 59651-422-01. The label indicates the product contains 100 capsules for prescription use only, with each capsule providing 30 mg of Cevimeline hydrochloride. Distributed by Aurobindo Pharma USA, Inc., the label also includes storage instructions and a barcode.*
FDA Label Image

Str (Cevimeline Str)

Str (Cevimeline Str)
Chemical structure of Cevimeline Hydrochloride, shown with a molecular diagram including a heterocyclic ring, sulfur and oxygen atoms, a methyl group, and associated hydrochloride and hemihydrate components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.